Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Donepezil in Patients With Chronic Tinnitus
Sponsor: University of Sao Paulo
Summary
This study is a prospective, placebo-controlled, randomized, double-blind clinical trial, including 70 patients with chronic sensorineural tinnitus, divided into placebo and treatment groups. Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2021-11-19
Completion Date
2025-12-09
Last Updated
2025-09-04
Healthy Volunteers
No
Conditions
Interventions
Donepezil group
Participants received donepezil for 3 months, starting with 5 mg daily for the first month and 10 mg daily for the following two months
Placebo group
35 Pacients with tinnitus received for 3 months placebo medication
Locations (1)
Universidade De São Paulo
São Paulo, São Paulo, Brazil